Skyhawk Therapeutics, Inc.
Clinical trials sponsored by Skyhawk Therapeutics, Inc., explained in plain language.
-
New pill aims to tackle Huntington's at its source
Disease control OngoingThis study tests an oral drug called SKY-0515 in 120 adults with Huntington's disease. The goal is to see if it can lower a harmful protein linked to the disease and improve symptoms. Participants take the drug or a placebo for a set period, and researchers monitor changes in pro…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
Hope for Huntington's: new pill targets harmful proteins in Long-Term study
Disease control ENROLLING_BY_INVITATIONThis study tests an oral drug called SKY-0515 in 500 adults with Huntington's disease who have already taken it in a previous study. The goal is to see if the drug can safely lower harmful proteins and improve symptoms over time. Participants must be 25 or older and have a geneti…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC